These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 1958539

  • 1. Steroids and hypertension.
    Mantero F, Armanini D, Boscaro M, Carpenè G, Fallo F, Opocher G, Rocco S, Scaroni C, Sonino N.
    J Steroid Biochem Mol Biol; 1991; 40(1-3):35-44. PubMed ID: 1958539
    [Abstract] [Full Text] [Related]

  • 2. New aspects of mineralocorticoid hypertension.
    Mantero F, Armanini D, Biason A, Boscaro M, Carpenè G, Fallo F, Opocher G, Rocco S, Scaroni C, Sonino N.
    Horm Res; 1990; 34(3-4):175-80. PubMed ID: 2151775
    [Abstract] [Full Text] [Related]

  • 3. The mineralocorticoid hormone pathways in hypertension with hyperaldosteronism.
    Biglieri EG, Kater CE, Brust N, Chang B, Hirai J.
    Clin Exp Hypertens A; 1982; 4(9-10):1677-83. PubMed ID: 7139973
    [Abstract] [Full Text] [Related]

  • 4. Defective fasciculata zone function as the mechanism of glucocorticoid-remediable aldosteronism.
    Ulick S, Chan CK, Gill JR, Gutkin M, Letcher L, Mantero F, New MI.
    J Clin Endocrinol Metab; 1990 Nov; 71(5):1151-7. PubMed ID: 2172271
    [Abstract] [Full Text] [Related]

  • 5. Steroid characteristics of mineralocorticoid adrenocortical hypertension.
    Biglieri EG, Kater CE.
    Clin Chem; 1991 Oct; 37(10 Pt 2):1843-8. PubMed ID: 1914200
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regulation of the mineralocorticoid hormones in adrenocortical disorders with adrenocorticotropin excess.
    Kater CE, Biglieri EG, Brust N, Chang B, Hirai J.
    Clin Exp Hypertens A; 1982 Oct; 4(9-10):1749-58. PubMed ID: 6291814
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Investigating mineralocorticoid hypertension.
    Nussberger J.
    J Hypertens Suppl; 2003 May; 21(2):S25-30. PubMed ID: 12929904
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Mineralocorticoid-induced hypertension].
    Hensen J, Oelkers W.
    Med Klin (Munich); 1997 May 15; 92(5):273-8. PubMed ID: 9244833
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [In vivo and in vitro studies on 18-hydroxy-11-deoxycorticosterone and 18-hydroxycorticosterone in normal subjects and in those with various adrenocortical disorders (author's transl)].
    Ojima M, Kambegawa A.
    Nihon Naibunpi Gakkai Zasshi; 1979 Aug 20; 55(8):994-1006. PubMed ID: 226427
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Primary aldosteronism: hypertension with a genetic basis.
    Gordon RD, Klemm SA, Tunny TJ, Stowasser M.
    Lancet; 1992 Jul 18; 340(8812):159-61. PubMed ID: 1352575
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.